Your browser doesn't support javascript.
loading
Teplizumab approval for type 1 diabetes in the USA.
Beran, David; Abidha, Carol; Adler, Amanda; de Beaufort, Carine; Lepeska, Molly; Levitt, Naomi; Pfiester, Elizabeth; Zafra-Tanaka, Jessica H; Gale, Edwin Am.
Afiliación
  • Beran D; Division of Tropical and Humanitarian Medicine, Faculty of Medicine and University Hospital, University of Geneva, Geneva 1211, Switzerland. Electronic address: david.beran@unige.ch.
  • Abidha C; Heidelberg Institute of Global Health, Faculty of Medicine and University Hospital, Heidelberg University, Heidelberg, Germany.
  • Adler A; Oxford Centre for Diabetes Endocrinology and Metabolism, Oxford University, Oxford, UK.
  • de Beaufort C; Department of Pediatric Endocrinology and Diabetes, Centre Hospitalier de Luxembourg, Luxembourg, Luxembourg; Faculty of Science, Technology and Medicine, University of Luxembourg, Luxembourg, Luxembourg; Department of Pediatric Endocrinology, UZ Brussel, Vrije Universiteit Brussel, Brussels, Belgiu
  • Lepeska M; Health Action International, Amsterdam, Netherlands.
  • Levitt N; Chronic Disease Initiative for Africa, Department of Medicine, University of Cape Town, Cape Town, South Africa.
  • Pfiester E; T1International, Cheltenham, UK.
  • Zafra-Tanaka JH; Division of Tropical and Humanitarian Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland; CRONICAS Centre of Excellence in Chronic Diseases, Universidad Peruana Cayetano Heredia, Lima, Peru.
  • Gale EA; Bristol Medical School, University of Bristol, Bristol, UK.
Lancet Diabetes Endocrinol ; 11(2): 78-80, 2023 02.
Article en En | MEDLINE | ID: mdl-36623522
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 1 / Anticuerpos Monoclonales Humanizados Límite: Humans Idioma: En Revista: Lancet Diabetes Endocrinol Año: 2023 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Diabetes Mellitus Tipo 1 / Anticuerpos Monoclonales Humanizados Límite: Humans Idioma: En Revista: Lancet Diabetes Endocrinol Año: 2023 Tipo del documento: Article